Seroatlas · Human Serome Atlas

CCN2

CCN family member 2

Also known as: CCN2_HUMAN, CTGF, IGFBP8

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P29279
Gene
CCN2
Ensembl
ENSG00000118523
Chromosome
6
Canonical length
349 aa
Protein class
Cancer-related genes, Plasma proteins, Predicted secreted proteins
Subcellular location
Golgi apparatus,Vesicles
Secretome location
Secreted in other tissues

OverviewNCBI Gene

The protein encoded by this gene is a mitogen that is secreted by vascular endothelial cells. The encoded protein plays a role in chondrocyte proliferation and differentiation, cell adhesion in many cell types, and is related to platelet-derived growth factor. Certain polymorphisms in this gene have been linked with a higher incidence of systemic sclerosis. [provided by RefSeq, Nov 2009]

Canonical amino-acid sequenceUniProt

349 residues, UniProt reviewed canonical sequence.

>P29279|CCN2
     1  MTAASMGPVR VAFVVLLALC SRPAVGQNCS GPCRCPDEPA PRCPAGVSLV LDGCGCCRVC
    61  AKQLGELCTE RDPCDPHKGL FCHFGSPANR KIGVCTAKDG APCIFGGTVY RSGESFQSSC
   121  KYQCTCLDGA VGCMPLCSMD VRLPSPDCPF PRRVKLPGKC CEEWVCDEPK DQTVVGPALA
   181  AYRLEDTFGP DPTMIRANCL VQTTEWSACS KTCGMGISTR VTNDNASCRL EKQSRLCMVR
   241  PCEADLEENI KKGKKCIRTP KISKPIKFEL SGCTSMKTYR AKFCGVCTDG RCCTPHRTTT
   301  LPVEFKCPDG EVMKKNMMFI KTCACHYNCP GDNDIFESLY YRKMYGDMA

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CCN2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Secreted
Secreted
Yes
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.42
Highest tissue expression
1,230 nTPM

Expression across tissuesHPA

Tissue

  • blood vessel: 1,230 nTPM
  • smooth muscle: 538 nTPM
  • spleen: 537 nTPM
  • cervix: 498 nTPM
  • thyroid gland: 436 nTPM
  • gallbladder: 413 nTPM

Single-cell type

  • hepatic stellate cells: 2,033 nCPM
  • podocytes: 980 nCPM
  • pancreatic duct cells: 628 nCPM
  • endometrial ciliated cells: 523 nCPM
  • peritubular myoid cells: 439 nCPM
  • vascular endothelial cells: 413 nCPM

Immune cell

  • naive B-cell: 8.1 nTPM
  • memory B-cell: 1.1 nTPM
  • total PBMC: 0.2 nTPM
  • basophil: 0 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM

Brain region

  • midbrain: 53 nTPM
  • choroid plexus: 51 nTPM
  • cerebral cortex: 38 nTPM
  • thalamus: 29 nTPM
  • hippocampal formation: 28 nTPM
  • pons: 27 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about CCN2.

Disease | AllUniProt

Conditions CCN2 is implicated in, by any mechanism.

Disease | GeneticClinVar

3 pathogenic / likely-pathogenic of 64 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.06
gnomAD pLI
0
DepMap mean gene effect
0.13
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of CCN2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CCN2 as an antibody target. Whether an autoantibody or antibody against CCN2 could matter depends on whether native CCN2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CCN2 is annotated as secreted, so native CCN2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.

Annotation status

The present source text does not explicitly label CCN2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/CCN2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...